. Author manuscript; available in PMC: 2012 Apr 24.

Published in final edited form as: J Steroid Biochem Mol Biol. 2011 Mar 21;127(1-2):16–26. doi: 10.1016/j.jsbmb.2011.03.011

Table 4.

Associations of PFAA exposures with immune end points in lactating women from the MAMA study.

Immunoglobulin_{media visit}	PFAA_{media visit}	Rho (p-value)
IgE_S1	PFHxS_S1	−0.29 (0.0954)
IgE_S1	PFOS_S1	−0.33 (0.0543)
IgE_S1	Total PFC_S1	−0.31 (0.0777)
IgE_S2	PFHxS_S2	−0.40 (0.0266)
IgE_S2	PFOS_S2	−0.48 (0.0072)
IgE_S2	Total PFC_S2	−0.46 (0.0098)
Secretory IgA_M1	PFHxS_S1	−0.47 (0.0059)
Secretory IgA_M2	PFNA_S2	−0.388 (0.045)
IgM_S2	PFOSA_S2	−0.36(0.050)

Spearman correlations between serum PFAA concentrations and data on serum or milk PFAA concentrations and data on serum or milk immunoglobulins (S is serum; M is milk). Visit number (1 or 2) is shown as a subscript for the matrix analyzed (milk or serum). Bolded associations were significant based on p < 0.05.